SeaStar Medical Holding Corporation (ICUCW)Denver, United States | NasdaqCM
0.03 USD
0.00
(-11.034%) ⇩
(July 13, 2026, 3:27 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 5:22 a.m. EDT
The security presents a catastrophic long-term investment case due to severe fundamental deterioration. Despite a headline-grabbing 68.9% revenue growth, the company is hemorrhaging cash with operating cash flow of -$13.7 million and free cash flow of -$9.6 million. The balance sheet is fragile, showing negative returns on both assets and equity, and the market has priced this reality into a price-to-book ratio of merely 0.016, indicating the stock trades at a fraction of its book value because investors see no path to profitability. The lack of any price history over the last year prevents assessing a multi-year trend, but the current operational bleed is undeniable. There is no dividend to provide income, and the recent news regarding shareholder losses suggests significant distress. While the short-term statistical model hints at a potential bounce, the underlying business quality is objectively broken, making this a clear avoid. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.002122 |
| MSTL | 0.002236 |
| AutoARIMA | 0.004169 |
| AutoTheta | 0.009062 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 65% |
| H-stat | 1.00 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 5.82 |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 4.525 |
| Revenue per Share | 0.506 |
| Beta | -1.03 |
| Previous Name | LMF Acquisition Opportunities, Inc. |
| Website | https://seastarmedical.com |
| Attribute | Value |
|---|---|
| Address1 | 3,513 Brighton Boulevard |
| Address2 | Suite 410 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | -1.032 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 1.832 |
| City | Denver |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0258 |
| Current Ratio | 2.726 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0258 |
| Day Low | 0.0186 |
| Debt To Equity | 4.525 |
| Display Name | SeaStar Medical Holding |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0258 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.0186 |
| Fifty Two Week Low Change | 0.007200001 |
| Fifty Two Week Low Change Percent | 0.38709682 |
| Fifty Two Week Range | 0.0186 - 0.0258 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,783,690,200,000 |
| Float Shares | 3,952,076 |
| Free Cashflow | -9,609,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 17 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.93106 |
| Gross Profits | 1,337,000 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Language | en-US |
| Long Business Summary | SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado. |
| Long Name | SeaStar Medical Holding Corporation |
| Market | us_market |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_111447 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -11,899,000 |
| Open | 0.0375 |
| Operating Cashflow | -13,706,000 |
| Operating Margins | -7.2787905 |
| Phone | 844 427 8100 |
| Prev Name | LMF Acquisition Opportunities, Inc. |
| Previous Close | 0.029 |
| Price Hint | 4 |
| Price To Book | 0.01408297 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.413 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0031999983 |
| Regular Market Change Percent | -11.034477 |
| Regular Market Day High | 0.0258 |
| Regular Market Day Low | 0.0186 |
| Regular Market Day Range | 0.0186 - 0.0258 |
| Regular Market Open | 0.0375 |
| Regular Market Previous Close | 0.029 |
| Regular Market Price | 0.0258 |
| Regular Market Time | 1,783,970,857 |
| Regular Market Volume | 6,071 |
| Return On Assets | -0.79241997 |
| Return On Equity | -3.02005 |
| Revenue Growth | 0.689 |
| Revenue Per Share | 0.506 |
| Sand P52 Week Change | 0.20847368 |
| Sector | |
| Sector Key | |
| Source Interval | 15 |
| State | CO |
| Symbol | ICUCW |
| Total Cash | 9,348,000 |
| Total Cash Per Share | 2.339 |
| Total Debt | 331,000 |
| Total Revenue | 1,436,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 6,071 |
| Website | https://seastarmedical.com |
| Zip | 80,216 |